Startup Dossier
OWLO
OWLO is a deeptech spin-off from Institut Langevin (ESPCI, CNRS, PSL) developing a real-time, 3D, label-free microscopy technology for medical and pharmaceutical applications. Its imaging module, powered by advanced optics and AI, allows clinicians and researchers to visualize oocytes, embryos, and organoids in 3D — dramatically enhancing IVF assessment accuracy and enabling breakthroughs in drug discovery and ophthalmology.
About
OWLO is a deeptech spin-off from Institut Langevin (ESPCI, CNRS, PSL) developing a real-time, 3D, label-free microscopy technology for medical and pharmaceutical applications. Its imaging module, powered by advanced optics and AI, allows clinicians and researchers to visualize oocytes, embryos, and organoids in 3D — dramatically enhancing IVF assessment accuracy and enabling breakthroughs in drug discovery and ophthalmology.
Structural DNA
Legal Name
OWLO
SIREN
934661026
Founders & Team
Funding Lineage
Pre Seed
daphni (Lead)
€2.5M
Nov 2025